CymitQuimica logo

11α-Methylandrostan-17β-ol-3-one

CAS:

Ref. 3D-FM32442

1g
449.00€
2g
612.00€
250mg
187.00€
500mg
296.00€
11α-Methylandrostan-17β-ol-3-one
Biosynth

Product Information

Name:11α-Methylandrostan-17β-ol-3-one
Controlled Product
Synonyms:
  • Mesterolone
Brand:Biosynth
Description:11alpha-Methylandrostan-17beta-ol-3-one is a pharmacological agent that belongs to the group of androgens. It is an oral preparation and has been used in the treatment of infectious diseases, autoimmune diseases, and metabolic disorders. It has also been used as a matrix effect control in biological samples. The biological effects of 11alpha-Methylandrostan-17beta-ol-3-one are mediated by its direct action on cells or through conversion to testosterone or dihydrotestosterone (DHT). These effects include increasing protein synthesis, promoting bone formation, lowering cholesterol levels, stimulating the production of red blood cells, and decreasing fat deposition. The main side effects are acne vulgaris, male pattern baldness, prostate enlargement, increased risk for prostate cancer, and increased risk for developing breast cancer.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:304.47 g/mol
Formula:C20H32O2
Purity:Min. 95%
Color/Form:Powder

Technical inquiry about: 11α-Methylandrostan-17β-ol-3-one

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.